Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity

Comparing SARS-CoV-2 infection-induced gene expression signatures to drug treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose existing drugs against SARS-CoV-2. The general hypothesis of signature-based drug repurposing is that drugs with inverse similarity to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Barsi, Szilvia (VerfasserIn) , Papp, Henrietta (VerfasserIn) , Valdeolivas, Alberto (VerfasserIn) , Tóth, Dániel J. (VerfasserIn) , Kuczmog, Anett (VerfasserIn) , Madai, Mónika (VerfasserIn) , Hunyady, László (VerfasserIn) , Várnai, Péter (VerfasserIn) , Sáez Rodríguez, Julio (VerfasserIn) , Jakab, Ferenc (VerfasserIn) , Szalai, Bence (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 11, 2022
In: PLoS Computational Biology
Year: 2022, Jahrgang: 18, Heft: 4, Pages: 1-20
ISSN:1553-7358
DOI:10.1371/journal.pcbi.1010021
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1371/journal.pcbi.1010021
Verlag, kostenfrei, Volltext: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1010021
Volltext
Verfasserangaben:Szilvia Barsi, Henrietta Papp, Alberto Valdeolivas, Dániel J. Tóth, Anett Kuczmog, Mónika Madai, László Hunyady, Péter Várnai, Julio Saez-Rodriguez, Ferenc Jakab, Bence Szalai

MARC

LEADER 00000caa a2200000 c 4500
001 1823261604
003 DE-627
005 20231107083714.0
007 cr uuu---uuuuu
008 221123s2022 xx |||||o 00| ||eng c
024 7 |a 10.1371/journal.pcbi.1010021  |2 doi 
035 |a (DE-627)1823261604 
035 |a (DE-599)KXP1823261604 
035 |a (OCoLC)1361670532 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Barsi, Szilvia  |e VerfasserIn  |0 (DE-588)1308883587  |0 (DE-627)1869493869  |4 aut 
245 1 0 |a Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity  |c Szilvia Barsi, Henrietta Papp, Alberto Valdeolivas, Dániel J. Tóth, Anett Kuczmog, Mónika Madai, László Hunyady, Péter Várnai, Julio Saez-Rodriguez, Ferenc Jakab, Bence Szalai 
264 1 |c April 11, 2022 
300 |b Illustrationen 
300 |a 20 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.11.2023 
520 |a Comparing SARS-CoV-2 infection-induced gene expression signatures to drug treatment-induced gene expression signatures is a promising bioinformatic tool to repurpose existing drugs against SARS-CoV-2. The general hypothesis of signature-based drug repurposing is that drugs with inverse similarity to a disease signature can reverse disease phenotype and thus be effective against it. However, in the case of viral infection diseases, like SARS-CoV-2, infected cells also activate adaptive, antiviral pathways, so that the relationship between effective drug and disease signature can be more ambiguous. To address this question, we analysed gene expression data from in vitro SARS-CoV-2 infected cell lines, and gene expression signatures of drugs showing anti-SARS-CoV-2 activity. ... 
650 4 |a Antivirals 
650 4 |a Cell membranes 
650 4 |a Chlorpromazine 
650 4 |a Cholesterol 
650 4 |a Drug therapy 
650 4 |a Gene expression 
650 4 |a SARS CoV 2 
650 4 |a Transcription factors 
700 1 |a Papp, Henrietta  |e VerfasserIn  |4 aut 
700 1 |a Valdeolivas, Alberto  |e VerfasserIn  |0 (DE-588)121954048X  |0 (DE-627)1735483141  |4 aut 
700 1 |a Tóth, Dániel J.  |e VerfasserIn  |4 aut 
700 1 |a Kuczmog, Anett  |e VerfasserIn  |4 aut 
700 1 |a Madai, Mónika  |e VerfasserIn  |4 aut 
700 1 |a Hunyady, László  |e VerfasserIn  |4 aut 
700 1 |a Várnai, Péter  |e VerfasserIn  |4 aut 
700 1 |a Sáez Rodríguez, Julio  |d 1978-  |e VerfasserIn  |0 (DE-588)133764362  |0 (DE-627)555766632  |0 (DE-576)300083114  |4 aut 
700 1 |a Jakab, Ferenc  |e VerfasserIn  |4 aut 
700 1 |a Szalai, Bence  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |a Public Library of Science  |t PLoS Computational Biology  |d San Francisco, Calif. : Public Library of Science, 2005  |g 18(2022), 4, Artikel-ID e1010021, Seite 1-20  |h Online-Ressource  |w (DE-627)491436017  |w (DE-600)2193340-6  |w (DE-576)273890492  |x 1553-7358  |7 nnas 
773 1 8 |g volume:18  |g year:2022  |g number:4  |g elocationid:e1010021  |g pages:1-20  |g extent:20  |a Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity 
856 4 0 |u https://doi.org/10.1371/journal.pcbi.1010021  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1010021  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20221123 
993 |a Article 
994 |a 2022 
998 |g 133764362  |a Sáez Rodríguez, Julio  |m 133764362:Sáez Rodríguez, Julio  |d 910000  |d 912900  |e 910000PS133764362  |e 912900PS133764362  |k 0/910000/  |k 1/910000/912900/  |p 9 
998 |g 121954048X  |a Valdeolivas, Alberto  |m 121954048X:Valdeolivas, Alberto  |d 910000  |d 950000  |d 950950  |e 910000PV121954048X  |e 950000PV121954048X  |e 950950PV121954048X  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950950/  |p 3 
999 |a KXP-PPN1823261604  |e 4218562393 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"April 11, 2022","dateIssuedKey":"2022"}],"physDesc":[{"noteIll":"Illustrationen","extent":"20 S."}],"recId":"1823261604","id":{"doi":["10.1371/journal.pcbi.1010021"],"eki":["1823261604"]},"person":[{"family":"Barsi","display":"Barsi, Szilvia","given":"Szilvia","role":"aut"},{"role":"aut","given":"Henrietta","family":"Papp","display":"Papp, Henrietta"},{"given":"Alberto","role":"aut","family":"Valdeolivas","display":"Valdeolivas, Alberto"},{"role":"aut","given":"Dániel J.","family":"Tóth","display":"Tóth, Dániel J."},{"role":"aut","given":"Anett","display":"Kuczmog, Anett","family":"Kuczmog"},{"family":"Madai","display":"Madai, Mónika","role":"aut","given":"Mónika"},{"display":"Hunyady, László","family":"Hunyady","given":"László","role":"aut"},{"display":"Várnai, Péter","family":"Várnai","given":"Péter","role":"aut"},{"role":"aut","given":"Julio","display":"Sáez Rodríguez, Julio","family":"Sáez Rodríguez"},{"display":"Jakab, Ferenc","family":"Jakab","role":"aut","given":"Ferenc"},{"family":"Szalai","display":"Szalai, Bence","given":"Bence","role":"aut"}],"name":{"displayForm":["Szilvia Barsi, Henrietta Papp, Alberto Valdeolivas, Dániel J. Tóth, Anett Kuczmog, Mónika Madai, László Hunyady, Péter Várnai, Julio Saez-Rodriguez, Ferenc Jakab, Bence Szalai"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity","title_sort":"Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity"}],"relHost":[{"origin":[{"publisherPlace":"San Francisco, Calif.","dateIssuedDisp":"2005-","dateIssuedKey":"2005","publisher":"Public Library of Science"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"491436017","pubHistory":["1.2005 -"],"id":{"issn":["1553-7358"],"zdb":["2193340-6"],"eki":["491436017"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"name":{"displayForm":["publ. by the Public Library of Science (PLoS) in association with the International Society for Computational Biology (ISCB)"]},"part":{"pages":"1-20","text":"18(2022), 4, Artikel-ID e1010021, Seite 1-20","extent":"20","year":"2022","volume":"18","issue":"4"},"language":["eng"],"disp":"Public Library of SciencePLoS Computational Biology","title":[{"title_sort":"PLoS Computational Biology","title":"PLoS Computational Biology","subtitle":"a new community journal"}],"note":["Gesehen am 23. November 2020"],"corporate":[{"role":"aut","display":"Public Library of Science"}]}],"note":["Gesehen am 07.11.2023"]} 
SRT |a BARSISZILVCOMPUTATIO1120